Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8432957 | Cancer Epidemiology | 2018 | 15 Pages |
Abstract
Current public reporting schemes for cancer stage at diagnosis in England should use a complete-case specification (i.e. the number of staged cases forming the denominator) and be based on three-year reporting periods. Early stage indicators for the studied geographies should not be used in pay-for-performance schemes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Matthew E. Barclay, Georgios Lyratzopoulos, David C. Greenberg, Gary A. Abel,